Loading Events

Upcoming Events › Public Event

Events Search and Views Navigation

Event Views Navigation

April 2024

3Not30 Roundtable Series: Women’s Brain Health

Hosted by Women’s Health Access Matters (WHAM)

WHAM's 3Not30 Roundtable Series features five virtual dialogues focused on how we can accelerate research, innovation, and investment in women's health for disease and conditions that exclusively, disproportionately or differentially impact women. Join hosts for their next dialogue focused on women’s brain health, addressing the critical issue of sex bias in diseases like Alzheimer's where women are 2/3 of patients and caregivers. Leaders in the field will share cutting edge research and strategies to address gaps in awareness, funding, and…

April 18 @ 1:00 pm - 2:00 pm EDT

OADR-ORWH Science Talks: Xist-ing Data: Why Might Autoimmune Diseases Be More Common in Women?

Hosted by NIH Office of Research on Women’s Health

The purpose of the OADR-ORWH Science Talks series is to examine the state of the science in specific areas impacting research on autoimmune disease and women’s health. This session of Science Talks is focused on Xist research and will bring together experts in the field to generate discussion and identify opportunities to advance Xist research as it pertains to autoimmune diseases. Target Audience: This session is designed for a scientific audience with an interest in autoimmune disease research. The event is…

April 23 @ 12:00 pm - 2:00 pm EDT

Breaking Barriers in Alzheimer’s Disease: Perspectives on Early Stage Alzheimer’s

Hosted by SWHR

Approximately two-thirds of Alzheimer’s disease patients are women, as well as more than 60% of their caregivers. Stigma surrounding Alzheimer’s and dementia can cause some women to dismiss symptoms as normal aging or menopausal brain fog and delay talking to their health care provider. Moreover, coverage of screening and diagnostic tests can be difficult and confusing to navigate, also contributing to delays in diagnosing and treating Alzheimer’s.  An early diagnosis is essential for slowing the progression of Alzheimer’s disease, planning…

April 26 @ 12:00 pm - 12:30 pm EDT

Essential Health Care Services Related to Anxiety and Mood Disorders in Women: A Workshop

Hosted by National Academies of Sciences, Engineering, and Medicine

The National Academies of Sciences, Engineering, and Medicine’s Forum on Mental Health and Substance Use Disorders will organize and host a public workshop to identify essential health care services related to anxiety and mood disorders in women. Invited presentations and discussions will be designed to: Identify essential health care services related to anxiety and mood disorders in women; Define essential health care services related to anxiety and mood disorders in women based on currently available evidence; Identify ways to prepare…

April 29 - April 30

May 2024

Exploring Obesity’s Impact on Women and Policy’s Role in Improving Outcomes

Hosted by SWHR

Obesity is a significant public health issue in the United States, affecting millions of Americans and costing billions of dollars in health care expenses. Women are disproportionately affected by the obesity epidemic, both in terms of their health outcomes and the economic costs of the disease. There are also notable racial and economic disparities associated with obesity. During this congressional briefing, panelists will explore the disproportionate impact of obesity on women, including obesity risk factors that are unique to women,…

May 2 @ 10:00 am - 11:00 am EDT
Rayburn House Office Building, 45 Independence Ave SW
Washington, DC 20515 United States

SWHR Pre-Conference Symposium: Lights, Camera, and Action to Improve Women’s Heart Health

Hosted by SWHR

Part of the OSSD Annual Meeting This event is taking place on Sunday, May 5 at 12:10-2:05 p.m. CET, in-person in Bergen, Norway. The Society for Women’s Health Research (SWHR) is committed to advancing women’s health through science, policy, and education while promoting research on sex differences to optimize women’s health. Although research has documented sex differences in heart health and disease, insufficient attention to the study of sex, gender, and hormones in cardiovascular research and a lack of inclusion…

May 5 @ 6:10 am - 8:05 am EDT

OSSD 2024 Annual Meeting

Hosted by Organization for the Study of Sex Differences (OSSD)

This is the annual meeting for the Organization for the Study of Sex Differences (OSSD). The OSSD 2024 Annual Meeting is taking place in Bergen, Norway this May. OSSD was founded in 2006 by member scientists and staff of the Society for Women's Health Research (SWHR). From 2006-2012, OSSD operated as a program of the SWHR, and in 2012 became an independent non-profit educational organization. The OSSD gratefully acknowledges the efforts of the SWHR in the creation, staffing, and funding…

May 6 - May 9

SWHR Emerging Scholars in Women’s Health Research Award  Symposium

Hosted by Organization for the Study of Sex Differences (OSSD)

The SWHR Emerging Scholars in Women’s Health Research Award is given to trainees whose abstracts submitted to the OSSD Annual Meeting demonstrate research excellence in addressing important knowledge gaps in health and disease areas that disproportionately, differently, or exclusively affect women.

May 6 @ 9:15 am - May 9 @ 11:00 am EDT

National Menstrual Health Awareness Month 2024

Hosted by The Fibroid Foundation

REGISTER

May 8 @ 3:00 pm - 4:00 pm EDT
Rayburn House Office Building, 45 Independence Ave SW
Washington, DC 20515 United States

VCU Health of Women 2024 | Emerging Topics in Women’s Health: Autoimmune Disease Challenge

Hosted by SWHR

Join us for the VCU Health of Women Conference 2024 SWHR Pre-conference Symposium! This symposium will discuss the impacts of autoimmune diseases on women’s health across the lifespan, with special emphasis on pregnancy and maternal health, caregiving/parenting.

May 9 @ 12:00 pm - 1:30 pm EDT
+ Export Events

Speakers

Irene O. Aninye, PhD
Chief Science Officer, Society for Women's Health Research
Irene O. Aninye, PhD
Chief Science Officer, Society for Women's Health Research

Dr. Irene Aninye is the Chief Science Officer at the Society for Women’s Health Research, a national nonprofit dedicated to improving women’s health through science, policy, and education. She steers SWHR’s science programs to increase investment in research on biological sex differences and awareness of health conditions and diseases that differently, disproportionately, or exclusively affect women. Prior to SWHR, Aninye led strategy teams for the American Association for the Advancement of Science (AAAS) to build research capacity and competitiveness and evaluate STEM research and training programs for universities and national consortia. Dr. Aninye’s research background in endocrinology and metabolism investigated sex steroid hormone-receptor action in development, reproduction, and disease. She also brings expertise in facilitating scientific and leadership development training for researchers and professionals across all career stages, and service on advisory boards for organizations such as the National Institutes of Health, American Cancer Society, National Health Council, and Endocrine Society USA. A Washington, DC, native, Aninye earned her BS in Biochemistry as a Meyerhoff Scholar at the University of Maryland Baltimore County and a PhD in Molecular and Integrative Physiology from the University of Illinois at Urbana-Champaign. 

Stacie Bell, PhD
Executive Vice President, Lupus Therapeutics
Stacie Bell, PhD
Executive Vice President, Lupus Therapeutics

Stacie is a dynamic leader and researcher with 25+ years of diverse experience in biotechnology, academic, nonprofit and pharma in discovery research, drug and device development, scientific strategy, education and patient centricity with a cross functional focus on clinical development and medical affairs. She has been involved with all phases and functional lines of the pre-clinical research and clinical development process in several therapeutic areas, including infectious diseases, immunology, rheumatology, dermatology, and has worked extensively with the FDA, NIH and NHC. Stacie currently leads Lupus Therapeutics, the clinical affiliate of the Lupus Research Alliance and oversees the LuCIN clinical trial network, a variety of partnerships advancing treatment development in lupus, and the patient engagement and health equity functions for the LRA. She has served in several leadership roles including Chief Scientific & Medical Officer for the National Psoriasis Foundation, on numerous boards and committees, consulted for late-stage discovery and clinical development programs in a variety of settings and has been the therapeutic area representative and program lead for her organizations. Stacie received her doctorate in biochemistry from Vanderbilt University and has secondary training in Clinical Pharmacology and Research. Throughout her career she has been dedicated to optimizing treatment options for unmet needs, promoting education, improving access to care, fostering partnership to progress programs and taking innovative approaches for program strategy.

Estela Mata-Carcamo
President, Looms for Lupus 
Estela Mata-Carcamo
President, Looms for Lupus 

Estela Mata-Carcamo is a tireless advocate for health equity, leading transformative initiatives at the intersection of healthcare, community engagement, and patient empowerment. As the President and Co-founder of Looms for Lupus, she drives awareness and support for lupus, fibromyalgia, and mental health. Her leadership has positively impacted thousands of patients and caregivers through education, advocacy and support.

Estela engages with the community, empowering patients to use their voices, share their stories, and shape policy decisions. She is also an ambassador of hope and co-founder of Mata Advocacy and Support (MAS), an advocacy consulting firm dedicated to making a positive impact in the community.

With 30 years of healthcare experience, Estela bridges connections between all stakeholders: industry and patients alike. Fluent in both English and Spanish, she collaborates globally with entities such as the U.S. Department of Health and Human Services and the U.S. Food and Drug Administration. Estela actively participates in Congresswoman Grace Napolitano’s Mental Health Consortium and serves as Vice-Chair of the Board for the California Chronic Care Coalition.

 

Lindsey Miltenberger, MA
Chief Advocacy Officer, Society for Women's Health Research
Lindsey Miltenberger, MA
Chief Advocacy Officer, Society for Women's Health Research

Miltenberger provides oversight of SWHR’s government relations, communications, and advocacy functions. A member of SWHR’s senior team, she is responsible for helping to drive SWHR’s policy agenda, build relationships with key stakeholders and policymakers, and guide activities to improve women’s health through science, policy, and education.

Previously, Miltenberger served as the assistant director of government affairs for the American Association for Dental Research (AADR), where she was responsible for developing and implementing AADR’s federal policy agenda, spanning federal budget and appropriations issues, international scientific collaboration, scientific workforce matters, and tobacco policy.

Prior to AADR, Miltenberger served as a senior manager for advocacy at AcademyHealth, where she supported efforts to raise the visibility and promote the value of health services and systems research.

Miltenberger received her master’s degree in global communication, with a concentration in public diplomacy, from The George Washington University. She received her ABJ in public relations and her BA in international affairs from the University of Georgia.

JoAnn V. Pinkerton, MD
Mamie A. Jessup Professor of Obstetrics and Gynecology, Division Director of Midlife Health, University of Virginia
JoAnn V. Pinkerton, MD
Mamie A. Jessup Professor of Obstetrics and Gynecology, Division Director of Midlife Health, University of Virginia

JoAnn Pinkerton is the Mamie A. Jessup Professor of Obstetrics and Gynecology, Division Director of Midlife Health at the University of Virginia, emeritus Executive Director and Past President of The Menopause Society, Certified Menopause Practitioner, American College of Obstetricians and Gynecologists Fellow and past president of the South Atlantic Association of Obstetrics and Gynecology.

She was recognized in 2021 and 2022 by PubMed as one of the top three in the world for menopause publications. Her awards: 2022 SAAOG Lifetime Achievement, 2019 UVA Master Clinician, Castle Connolly Exceptional Women in Medicine, UVA Sharon Hostler 2013 Women in Leadership, BEST DOCTORs, TOP DOCTORS in America, Top 1% by America’s Most Honored Professionals, and American Library Association Award for Understanding Midlife Health. She has 172 peer-reviewed publications, 30 invited papers, 18 invited chapters, principal investigator for over 30 clinical trials, recently for elinzanetant ( NK1, 3) dual neurokinin receptor antagonist for hot flashes.

She is the founder and division director for Midlife Health, which specializes in caring for women 40 and beyond. It offers outstanding, highly rated, evidence-driven expert care, serves as a site for medical and graduate medical education, conducts national clinical research, and is active within the community.


Sponsor

Support for this event has been provided by Johnson & Johnson. SWHR maintains independence and editorial control over program development, content, and work products.